Zhi Tong Cai Jing·2025-05-13 09:31Group 1 - JD Health reported Q1 2025 revenue of 16.645 billion RMB, a year-on-year increase of 25.5%, and operating profit of 1.071 billion RMB, up 119.8% [1] - JD Health solidified its position as the "first station for the online launch of new specialty drugs," introducing several innovative medications in Q1 2025, including products from Pfizer and Esteve [1] - The company deepened collaborations with leading health product firms, enhancing product innovation, digital supply chain, and precise marketing, aiming to expand the health consumption market [1] Group 2 - In Q1 2025, JD Health made significant advancements in the medical AI sector, applying AI technology in healthcare services, specialized disease treatment, and health management [2] - The launch of the "AI Jingyi" product system in January 2025 provided online multi-scenario applications, offering intelligent diagnostic assistance and personalized healthcare services [2] - Over 80% of doctor consultations in JD Health's internet hospital utilized AI services, with a 91% satisfaction rate for AI nutritionist services [2]